| 136 |
119: N/A, Gap |
49: Reduction, Ca and HCO3 transport to shell gland |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 996 |
139: N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects |
854: Alterations, Cellular proliferation / hyperplasia |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 593 |
590: N/A, hypoxia |
591: Increased, amputations |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3307 |
590: N/A, hypoxia |
1376: Increase, angiogenesis |
Jul 18, 2024 |
Jul 18, 2024 |
None
|
| 3370 |
590: N/A, hypoxia |
885: Increase, Cancer |
Oct 25, 2024 |
Oct 25, 2024 |
1 AOP
|
| 168 |
158: N/A, Interferences with SH-/selen-proteins |
130: Depletion, GSH |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2889 |
345: N/A, Liver Steatosis |
55: Cell injury/death |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 182 |
173: N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number |
321: N/A, Cyanosis occurs |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 207 |
352: N/A, Neurodegeneration |
188: Neuroinflammation |
Nov 29, 2016 |
Jun 13, 2018 |
2 AOPs
|
| 368 |
352: N/A, Neurodegeneration |
386: Neuronal network function, Decreased |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 647 |
352: N/A, Neurodegeneration |
618: Decreased, Neuronal network function in adult brain |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 1069 |
352: N/A, Neurodegeneration |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Apr 11, 2024 |
2 AOPs
|
| 2287 |
352: N/A, Neurodegeneration |
1841: Encephalitis |
Feb 23, 2021 |
Feb 23, 2021 |
2 AOPs
|
| 3070 |
352: N/A, Neurodegeneration |
388: Overactivation, NMDARs |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3075 |
352: N/A, Neurodegeneration |
637: impaired, Learning and memory |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3081 |
352: N/A, Neurodegeneration |
1348: Increase, seizure |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 242 |
213: N/A, Parent compound is converted to the reactive metabolite and forms free radicals leadin |
21: Altered regulation, Alpha hemoglobin |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 243 |
213: N/A, Parent compound is converted to the reactive metabolite and forms free radicals leadin |
118: Formation, Formation of hemoglobin adducts |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 245 |
213: N/A, Parent compound is converted to the reactive metabolite and forms free radicals leadin |
250: Damaging, Red blood cells; hemolysis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3323 |
213: N/A, Parent compound is converted to the reactive metabolite and forms free radicals leadin |
1392: Increase, Oxidative Stress |
Jul 24, 2024 |
Jul 24, 2024 |
1 AOP
|
| 650 |
634: N/A, sedation |
635: Decreased, locomotion |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 324 |
294: N/A, Unknown |
57: Proliferation, Cell proliferation in the absence of cytotoxicity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 751 |
294: N/A, Unknown |
759: Increased, Kidney Failure |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3148 |
1259: narcosis |
177: Increase, Mitochondrial dysfunction |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3754 |
1263: Necrosis |
2009: Activation, inflammation pathway |
Mar 25, 2026 |
Mar 25, 2026 |
1 AOP
|